AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma

Grace L. Su, Osama Altayar, Robert O’Shea, +5

Gastroenterology

HepatologyMedicineSystemic TreatmentHistopathologyPathology +5

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri, +162

The Lancet

HepatologyTransarterial ChemoembolisationMedicinePharmacologyPathology +6

Sorafenib in Advanced Hepatocellular Carcinoma

Bassam Estfan, Michael Byrne, Richard D. Kim

American Journal of Clinical Oncology

Recipient and Donor Outcomes After Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases

Roberto Hernandez‐Alejandro, Luis I. Ruffolo, Kazunari Sasaki, +21

JAMA Surgery

Prospective Clinical Study of Precision Oncology in Solid Tumors

Davendra Sohal, Brian I. Rini, Alok A. Khorana, +13

JNCI Journal of the National Cancer Institute

Epidemiology of Cholangiocarcinoma; United States Incidence and Mortality Trends

Mohamed M. Gad, Anas M. Saad, Mohammed Faisaluddin, +7

Clinics and Research in Hepatology and Gastroenterology

United States IncidenceEpidemiologySurgical OncologyCancer EpidemiologyHepatology +8

Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors

Shiva Shrotriya, Declan Walsh, Amy S. Nowacki, +7

PLoS ONE

Respiratory function during parenteral opioid titration for cancer pain

Bassam Estfan, Fade Mahmoud, Philip Shaheen, +7

Palliative Medicine

Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer

Yamu Li, Sulin Wu, Yiqing Zhao, +22

Journal of Clinical Investigation

Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation

Abhijeet Waghray, Galal El‐Gazzaz, Richard D. Kim, +5

Clinical Transplantation